NVCR - NovoCure GAAP EPS of -$0.31 beats by $0.09 revenue of $150.4M beats by $14.57M
2024-07-25 07:01:24 ET
More on NovoCure
- NovoCure Limited Q1 Earnings: Core Business Accelerating
- NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript
- NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation
- NovoCure Q2 2024 Earnings Preview
- NovoCure Tumor Treating Fields decreases progression of brain metastases